Management issues during HeartWare left ventricular assist device implantation and the role of transesophageal echocardiography.

Patangi, Sanjay Orathi; George, Anthony; Pauli, Henning; O'Leary, Denis; Roysam, Chandrika; Butt, Tanveer; Schueler, Stephan; Prabhu, Mahesh; MacGowan, Guy.
Ann Card Anaesth ; 2013 Oct; 16(4): 259-267
Artículo en Inglés | IMSEAR | ID: sea-149665

Documentos relacionados

  1. Management issues during HeartWare left ventricular assist device implantation and the role of transesophageal echocardiography.
  2. The Clinical Impact of Device Lead-Associated Tricuspid Regurgitation: Need for a Multidisciplinary Approach.
  3. Cardiac implantable electronic device-induced tricuspid regurgitation: Implications and management.
  4. Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural history.
  5. Right ventricle dysfunction assessment for transcatheter tricuspid valve repair: A matter of debate.
  6. Significance of strictly defined idiopathic tricuspid regurgitation.
  7. Valvular Regurgitation in a Biventricular Mock Circulatory Loop.
  8. Diagnosis and treatment of tricuspid valve disease: current and future perspectives.
  9. Impact of tricuspid regurgitation on right ventricular function and clinical outcomes in pulmonary arterial hypertension: food for thought.
  10. Echocardiographic diagnosis and clinical implications of wide-open tricuspid regurgitation for evaluating right ventricular dysfunction in the emergency department.